These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 22475546

  • 1. Transfusion induced Graft versus host disease - Case report in a 2 year child.
    Naveen KN, Kabbin GM, Kulkarni V, Pai VV, Rao R.
    Transfus Apher Sci; 2012 Aug; 47(1):17-9. PubMed ID: 22475546
    [Abstract] [Full Text] [Related]

  • 2. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
    Gilstad C, Roschewski M, Wells J, Delmas A, Lackey J, Uribe P, Popa C, Jardeleza T, Roop S.
    Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
    Liesveld J, Duerst R, Rapoport A, Constine L, Abboud C, Packman C, Wedow L, Zwetsch L, McKenna B, Linder T, Silverman W, Swift S, Rowe J, DiPersio J.
    Bone Marrow Transplant; 1999 Sep; 24(5):511-6. PubMed ID: 10482935
    [Abstract] [Full Text] [Related]

  • 6. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV.
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [Abstract] [Full Text] [Related]

  • 7. Treatment of GVHD after blood transfusion.
    Sakuma H, Kikuta A, Suzuki H.
    Fukushima J Med Sci; 1993 Dec; 39(2):113-6. PubMed ID: 7927134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
    Iravani M, Mousavi A, Gholibeikian S, Bahar B, Samiee S, Ashouri A, Eghbal L, Ghavamzadeh A.
    Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D, Duquesnoy R, Nichols L, Clark K, Jukic D, Zeevi A, Meisner D.
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [Abstract] [Full Text] [Related]

  • 18. Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion.
    Amrolia PJ, Rao K, Slater O, Ramsay A, Veys PA, Webb DK.
    Bone Marrow Transplant; 2001 Sep; 28(6):623-5. PubMed ID: 11607779
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.